Toll like receptor7 polymorphisms in relation to disease susceptibility and progression in Chinese patients with chronic HBV infection

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Zhu, Junping ^a   Zhang, Tong ^b   Cao, Lina ^a   Li, Aixin ^b   Zheng, Kai ^a   Zhang, Nan ^a   Su, Bin ^b   Chen, Zhiyun ^a   Chen, Ning ^a   Wu, Hao ^b   He, Qiushui ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TLR7 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 7;

ADOLESCENT; ADULT; AGED; ALLELE; CASE CONTROL STUDY; CHILD; CHINA; CHRONIC HEPATITIS B; DISEASE EXACERBATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHILD; CHINA; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 7;

EID: 85030329103     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-12698-5     Document Type: Article

References (40)

1. Ott, J. J., Stevens, G. A., Groeger, J. & Wiersma, S. T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30, 2212-2219 (2012).
2. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
3. Cui, Y. & Jia, J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 28(Suppl 1), 7-10 (2013).
4. CB, L. & CA, S. Hepatitis B vaccine and Problems. Chin J Epidemiol 25, 377-378 (2004).
5. Wang, F. S., Fan, J. G., Zhang, Z., Gao, B. & Wang, H. Y. The global burden of liver disease: the major impact of China. Hepatology 60, 2099-2108 (2014).
6. Garcia-Sastre, A. & Biron, C. A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312, 879-882 (2006).
7. Woltman, A. M., Op den Brouw, M. L., Biesta, P. J., Shi, C. C. & Janssen, H. L. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS One 6, e15324 (2011).
8. Lee, C. C., Avalos, A. M. & Ploegh, H. L. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 12, 168-179 (2012).
9. Isogawa, M., Robek, M. D., Furuichi, Y. & Chisari Francis, V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79, 7269-7272 (2005).
10. Ma, Z., Zhang, E., Yang, D. & Lu, M. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cell Mol Immunol 12, 273-282 (2015).
11. Skevaki, C., Pararas, M., Kostelidou, K., Tsakris, A. & Routsias, J. G. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol 180, 165-177 (2015).
12. Dunn, C. et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 1289-1300 (2009).
13. Vincent, I. E. et al. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One 6, e26315 (2011).
14. Lee, B. O. et al. Interaction of the hepatitis B core antigen and the innate immune system. J Immunol 182, 6670-6681 (2009).
15. Lanford R. E. et al. GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees. Gastroenterology 144, 1508-1517, 17 e1-10 (2013).
16. Du, X., Poltorak, A., Wei, Y. & Beutler, B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11, 362-371 (2000).
17. Shen, N. et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA 107, 15838-15843 (2010).
18. Xiao, W. et al. Association of Toll-like receptor 7 and 8 gene polymorphisms with Graves' disease in Chinese Cantonese population. Tissue antigens 85, 29-34 (2015).
19. Said, E. A. et al. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIVinfection. Immunol let 160, 58-64 (2014).
20. Schott, E. S. et al. A toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 47, 203-211 (2007).
21. Yue, M. et al. Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females. Infec Genet Evol 27, 264-270 (2014).
22. Wang, C. H. et al. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS One 6, e26235 (2011).
23. Kawasaki, A. et al. TLR7 single-nucleotide polymorphisms in the 3′ untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther 13, R41 (2011).
24. 1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68-74 (2015).
25. Funk, E., Kottilil, S., Gilliam, B. & Talwani, R. Tickling the TLR7 to cure viral hepatitis. J Transl Med 12, 129 (2014).
26. Xu, N., Yao, H. P., Lv, G. C. & Chen, Z. Downregulation of TLR7/9 leads to deficient production of IFN-alpha from plasmacytoid dendritic cells in chronic hepatitis B. Inflamm Res 61, 997-1004 (2012).
27. Wu, J. et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49, 1132-1140 (2009).
28. Wang, C. M. et al. Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci Rep 4, 3792 (2014).
29. Wu, Y. W., Tang, W. & Zuo, J. P. Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol Sin 36, 1395-1407 (2015).
30. Chang, J. J. & Lewin, S. R. Immunopathogenesis of hepatitis B virus infection. Immuno Cell Bio l85, 16-23 (2007).
31. Zhang, Y. L., Guo, Y. J., Bin, L. & Sun, S. H. Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7. J Hepatol 51, 29-38 (2009).
32. Yue, M. et al. Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection. Gene 548, 244-250 (2014).
33. Geier A., Gartung C. & Dietrich C. G. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma. N Engl J Med 347, 1721-1722; author reply 1721-1722 (2002).
34. Li, F. et al. Association between TLR7 copy number variations and hepatitis virus infection outcome in Chinese. World J Gastroenterol 23, 1602-1607 (2017).
35. Chen, C. J., Yang, H. I. & Iloeje, U. H. & REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49, S72-84 (2009).
36. Zhang, H. et al. Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China. Int J Med Sci 8, 321-331 (2011).
37. Fish, E. N. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8, 737-744 (2008).
38. Berghofer, B. et al. TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177, 2088-2096 (2006).
39. Meier, A. et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15, 955-959 (2009).
40. Croagh, C. M. & Lubel, J. S. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol 20, 10395-10404 (2014).